NanoStemCell

Ingredient science / Skin care

NanoStemCell

NanoStemCell™ Botanical Liposome Complex: Skin Renewal and Anti-Aging Care

Buddleja officinalis flower extract + Salvia miltiorrhiza root extract

Huzhou Puripharm Pharmaceutical Technology Co., Ltd.

Product overview · Full set of figures · November 2026

Product overview

A two-botanical ingredient blend

A water–polyol dispersion of botanical extracts and phospholipids for skin renewal, moisturization, and anti-aging formulations.

Schematic of the carrier structure. This image does not report particle-size measurements.

Recommended use level Formulation pH Processing temperature
0.1–5% 4–8 <80°C

Ingredient origins

Botanical sources

Buddleja officinalis

Flower extract

Salvia miltiorrhiza (danshen)

Root extract

Skin biology / Formulation context

Epidermal renewal and barrier formation

Schematic of normal epidermal physiology. It does not show results from an efficacy study of NanoStemCell.

[4] Blanpain C, Fuchs E. Nat Rev Mol Cell Biol. 2009;10:207–217. doi:10.1038/nrm2636.

Product composition

Ingredients and typical proportions

INCI name Range (w/w, %) Typical proportion (w/w, %)
WATER 15–35 32.5
BUTYLENE GLYCOL 15–35 30.0
PROPYLENE GLYCOL 15–35 32.0
PHOSPHOLIPIDS 1.5–10 3.5
BUDDLEJA OFFICINALIS EXTRACT 0.5–1.5 1.0
SALVIA MILTIORRHIZA EXTRACT 0.5–1.5 1.0

The typical composition totals 100.0%. These are supplier formulation figures and do not represent measurements of a specific batch.

Source: Supplier ingredient breakdown and composition table totaling 100%.

Carrier and production process

Preparing the botanical dispersion

Phospholipids act as a carrier component in the water–polyol dispersion of botanical extracts.

Research overview

Research on the botanical ingredients

Test material Experimental model Research focus
Buddleja officinalis extract [1] UVB-exposed HaCaT keratinocytes NRF2-related oxidative stress responses
Salvianolic acid B [2] UVB-exposed human dermal fibroblasts MAPK/AP-1 and extracellular matrix markers
Salvianolic acid B [3] Dermal fibroblasts and a mouse model of photoaging NRF2, mitochondria, and cellular senescence

The studies tested research extracts or isolated compounds. They do not establish the clinical efficacy of the NanoStemCell ingredient blend.

Sources: Zhu et al., 2025 [1]; Sun et al., 2015 [2]; Sun et al., 2024 [3].

Botanical ingredient research / In vitro study

Buddleja officinalis: Cellular antioxidant pathways

Experimental system

HaCaT keratinocytes; UVB: 30 mJ/cm²

Research extract, 62.5–250 µg/mL; 2-hour pretreatment

Study measure Direction of change
Reactive oxygen species / malondialdehyde (MDA) Decreased
SOD / GSH:GSSG Increased
NRF2, HO-1, and NQO1 Stronger associated responses
Cell viability Improved

Qualitative summary. The concentrations shown apply to the extract used in this study.

[1] Zhu X, et al. Pharm Biol. 2025;63:567–581. doi:10.1080/13880209.2025.2540348.

Isolated compound research / In vitro study

Salvia miltiorrhiza: Extracellular matrix pathways

Salvianolic acid B

Purified compound, 1–100 µg/mL; UVB-exposed human dermal fibroblasts

Pathway / measure Study observation
MAPK / AP-1 signaling Reduced activation
MMP-1 and IL-6 Reduced expression
Type I procollagen and TGF-β1 Increased

[2] Sun Z, et al. Photochem Photobiol. 2015;91:879–886. doi:10.1111/php.12427.

Isolated compound research / Preclinical study

Salvia miltiorrhiza: NRF2 and mitochondrial function

Salvianolic acid B

UVB-exposed dermal fibroblasts and a mouse model of photoaging

NRF2 · Activation

Mitochondria · Protection

Cellular senescence · Reduction

[3] Sun JM, et al. Phytomedicine. 2024;130:155676. doi:10.1016/j.phymed.2024.155676.

Supplier images / 01 of 08

Cell colony micrographs

About these eight supplier images: Although the figure labels say NanoStemCell™, the presentation identifies Revivyl™ as the test material in the source Word document. Interpret the findings for the original test material; they are not measurements of NanoStemCell efficacy.

Left: untreated cells. Right: the 0.5% formulation group as labeled. The panels show isolated cells and cell colonies, respectively.

The figure labels the cells as stem cells.

Supplier images / 02 of 08

Fluorescence images of the UV response

Left to right: untreated cells, UV-exposed cells, and UV-exposed cells with the 0.5% formulation shown in the label.

Original annotations: UV group −66%***; labeled formulation + UV group +171%***. *** t-test, P < 0.001.

Supplier images / 03 of 08

Ki67 histology

Left to right: untreated skin, comparator-treated skin, and the formulation group as labeled. Arrows indicate staining features.

Original annotations: comparator +19%; labeled formulation +84%.

Supplier images / 04 of 08

Imaging of differentiation markers

Rows: filaggrin, involucrin, and loricrin. Columns: untreated reconstructed human epidermis (RHE), comparator-treated RHE, and the 0.5% formulation group as labeled.

Original annotations (comparator / labeled formulation): filaggrin −51% / +250%; involucrin +191% / +490%; loricrin +154% / +470%.

Supplier images / 05 of 08

KLK5 immunostaining

Left to right: untreated skin, comparator-treated skin, and the formulation group as labeled. The image retains the KLK5 staining and the supplier’s original numerical annotations.

Original annotations: comparator −9%; labeled formulation +13%. Figure note: * t-test, P < 0.05.

Supplier images / 06 of 08

Histology of surface desquamation

Left to right: untreated skin, comparator-treated skin, and the formulation group as labeled. Numerical annotations are retained as shown in the source.

Original annotations: comparator −9%; labeled formulation +13%. Figure notes: * t-test, P < 0.05; *** t-test, P < 0.005.

Supplier images / 07 of 08

OCT images over time

Columns: comparator and the formulation group as labeled. Rows: days 1, 14, and 28. Arrows are retained as shown in the source.

Skin layers labeled in the image: epidermis and dermis.

Supplier images / 08 of 08

Photographs of silicone replicas of crow’s feet

Top row: comparator. Bottom row: the formulation group as labeled. In each row, replicas are shown from left to right for days 1, 14, and 28.

Application development

Skin care formulation applications

01 · Daily serums

Formulations for skin conditioning and improved skin texture.

02 · Day and night creams

Facial moisturization and anti-aging formulations.

03 · Body lotions for dry skin

Lotion formats for daily face and body care.

04 · Water-based skin care mists

Aqueous formats for daily skin care.

Formulation guidance

Recommended incorporation conditions

0.1–5.0% · Of the finished formulation

Item Recommendation
Temperature Below 80°C
Formulation pH 4.0–8.0
Mixing Gentle stirring

Add near the end of processing or to the aqueous phase.

Verify compatibility, stability, and performance in the finished formulation at the intended use level.

Use-level calculations

Ingredient contributions at different use levels

Estimated component concentrations in the finished formulation (w/w, %)

NanoStemCell use level 0.1% 1.0% 3.0% 5.0%
Buddleja officinalis extract 0.001 0.010 0.030 0.050
Salvia miltiorrhiza extract 0.001 0.010 0.030 0.050
Phospholipids 0.0035 0.035 0.105 0.175
Total polyols¹ 0.062 0.620 1.860 3.100

¹ Sum of propylene glycol and butylene glycol. Calculation: ingredient use level × typical proportion of the component.

Technical information

Quality specifications and storage

Quality parameter Specification
Appearance Pale yellow to yellow liquid
Total aerobic count ≤100 CFU/g
Yeasts and molds ≤10 CFU/g
Escherichia coli / Salmonella Not detected per g

Storage temperature · 4–25°C

Shelf life in unopened original packaging · 12 months

Protect from sunlight. Use plastic containers.

Research and product materials

References and source documents

Published research

[1] Zhu X, et al. Pharm Biol. 2025;63(1):567–581.doi:10.1080/13880209.2025.2540348

[2] Sun Z, et al. Photochem Photobiol. 2015;91(4):879–886.doi:10.1111/php.12427

[3] Sun JM, et al. Phytomedicine. 2024;130:155676.doi:10.1016/j.phymed.2024.155676

[4] Blanpain C, Fuchs E. Nat Rev Mol Cell Biol. 2009;10(3):207–217.doi:10.1038/nrm2636

Product source documents

Puripharm NanoStemCell product information, revision jv2; English product materials; supplier image set (nanostemcell_pic180709); ingredient composition table; origin statement; process documents; technical data; and certificate of analysis (COA) dated December 23, 2025.

Huzhou Puripharm Pharmaceutical Technology Co., Ltd.

NanoStemCell

Botanical research to support skin care formulation development

www.puriactives.com

service@puripharm.com | +86-572-2745768

Building 6, No. 1366 Hongfeng Road, Huzhou, Zhejiang, China

Posted in News.